239 related articles for article (PubMed ID: 19248972)
61. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.
Rink L; Skorobogatko Y; Kossenkov AV; Belinsky MG; Pajak T; Heinrich MC; Blanke CD; von Mehren M; Ochs MF; Eisenberg B; Godwin AK
Mol Cancer Ther; 2009 Aug; 8(8):2172-82. PubMed ID: 19671739
[TBL] [Abstract][Full Text] [Related]
62. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor.
Kleinbaum EP; Lazar AJ; Tamborini E; Mcauliffe JC; Sylvestre PB; Sunnenberg TD; Strong L; Chen LL; Choi H; Benjamin RS; Zhang W; Trent JC
Int J Cancer; 2008 Feb; 122(3):711-8. PubMed ID: 17943734
[TBL] [Abstract][Full Text] [Related]
63. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
ESMO / European Sarcoma Network Working Group
Ann Oncol; 2012 Oct; 23 Suppl 7():vii49-55. PubMed ID: 22997454
[No Abstract] [Full Text] [Related]
64. Management of gastrointestinal stromal tumors.
Hueman MT; Schulick RD
Surg Clin North Am; 2008 Jun; 88(3):599-614, vii. PubMed ID: 18514701
[TBL] [Abstract][Full Text] [Related]
65. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
[TBL] [Abstract][Full Text] [Related]
66. Imatinib mesylate in the treatment of gastrointestinal stromal tumour.
Steinert DM; McAuliffe JC; Trent JC
Expert Opin Pharmacother; 2005 Jan; 6(1):105-13. PubMed ID: 15709888
[TBL] [Abstract][Full Text] [Related]
67. [Efficacy of tyrosine kinase inhibitor therapy combined with surgical resection in patients with metastatic gastrointestinal stromal tumor].
Zhang XH; He YL; Chen CQ; Zhan WH; Ma JP; Cai SR; Wu KM; Chen JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jul; 13(7):502-5. PubMed ID: 20658363
[TBL] [Abstract][Full Text] [Related]
68. Novel approaches to imatinib- and sunitinib-resistant GIST.
Reichardt P
Curr Oncol Rep; 2008 Jul; 10(4):344-9. PubMed ID: 18778561
[TBL] [Abstract][Full Text] [Related]
69. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
70. Gastrointestinal stromal tumour of the rectum: report of a case and review of literature.
Grassi N; Cipolla C; Torcivia A; Mandala S; Graceffa G; Bottino A; Latteri F
World J Gastroenterol; 2008 Feb; 14(8):1302-4. PubMed ID: 18300363
[TBL] [Abstract][Full Text] [Related]
71. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation.
Antonescu CR; Besmer P; Guo T; Arkun K; Hom G; Koryotowski B; Leversha MA; Jeffrey PD; Desantis D; Singer S; Brennan MF; Maki RG; DeMatteo RP
Clin Cancer Res; 2005 Jun; 11(11):4182-90. PubMed ID: 15930355
[TBL] [Abstract][Full Text] [Related]
72. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
Caram MV; Schuetze SM
J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
[TBL] [Abstract][Full Text] [Related]
73. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Eisenberg BL; Harris J; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M
J Surg Oncol; 2009 Jan; 99(1):42-7. PubMed ID: 18942073
[TBL] [Abstract][Full Text] [Related]
74. Gastrointestinal stromal tumors.
Antonescu C
Curr Top Microbiol Immunol; 2012; 355():41-57. PubMed ID: 22015552
[TBL] [Abstract][Full Text] [Related]
75. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
76. Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations.
Blay JY; Reichardt P
Expert Rev Anticancer Ther; 2009 Jun; 9(6):831-8. PubMed ID: 19496720
[TBL] [Abstract][Full Text] [Related]
77. Practical aspects of managing gastrointestinal stromal tumors.
Sleijfer S; Seynaeve C; Wiemer E; Verweij J
Clin Colorectal Cancer; 2006 Nov; 6 Suppl 1():S18-23. PubMed ID: 17101064
[TBL] [Abstract][Full Text] [Related]
78. Gastrointestinal stromal tumors: a single institution experience of 50 cases.
Rajappa S; Muppavarapu KM; Uppin S; Digumarti R
Indian J Gastroenterol; 2007; 26(5):225-9. PubMed ID: 18227573
[TBL] [Abstract][Full Text] [Related]
79. microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.
Akçakaya P; Caramuta S; Åhlen J; Ghaderi M; Berglund E; Östman A; Bränström R; Larsson C; Lui WO
Br J Cancer; 2014 Nov; 111(11):2091-102. PubMed ID: 25349971
[TBL] [Abstract][Full Text] [Related]
80. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.
Blay JY; von Mehren M; Blackstein ME
Cancer; 2010 Nov; 116(22):5126-37. PubMed ID: 20661913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
